First experience of the AML‐Berlin‐Frankfurt‐Münster group in pediatric patients with standard‐risk acute promyelocytic leukemia treated with arsenic trioxide and all‐trans retinoid acid
- 23 January 2017
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 64 (8)
- https://doi.org/10.1002/pbc.26461
Abstract
Recently, studies in adults with acute promyelocytic leukemia (APL) showed high cure rates in low‐risk patients treated with all‐trans retinoid acid (ATRA) and arsenic trioxide (ATO), while toxicities were significantly reduced compared to the standard treatment with ATRA and chemotherapy. Here we report about first experience with 11 pediatric patients with low‐risk APL treated with ATRA and ATO. All patients stayed in molecular remission. All suffered from hyperleukocytosis. Two patients experienced reversible severe side effects. One suffered from osteonecroses at both femurs, seizures, as well as posterior reversible encephalopathy syndrome, the other patient had an abducens paresis.Keywords
This publication has 11 references indexed in Scilit:
- The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemiaBlood, 2016
- Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trialThe Lancet Oncology, 2015
- Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life OutcomesJournal of Clinical Oncology, 2014
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic LeukemiaNew England Journal of Medicine, 2013
- Effect of arsenic trioxide on the treatment of children with newly diagnosed acute promyelocytic leukemia in ChinaInternational Journal of Hematology, 2011
- Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up DataJournal of Clinical Oncology, 2010
- Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline dosesBritish Journal of Haematology, 2010
- Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemiaBlood, 2010
- Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: A single center experiencePediatric Blood & Cancer, 2008
- Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.Journal of Clinical Oncology, 1995